Lantern Pharma Inc. (LTRN) Free cash flow 2021–2025
Lantern Pharma Inc. (LTRN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.7MFY2025 · since FY2021: -$10.6M → -$15.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.7M | +12.0% |
| FY2024 | -$17.8M | -24.1% |
| FY2023 | -$14.4M | -12.3% |
| FY2022 | -$12.8M | -20.6% |
| FY2021 | -$10.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice